What is Amgen's revenue?

Amgen (AMGN) generated $37.2B in revenue over the trailing twelve months, up 9.1% year over year.

Amgen reported $7.8B in net income over the trailing twelve months, a 21.0% net margin.

What are Amgen's profit margins?

Gross margin is 68.3% and operating margin is 28.4%, with a 21.0% net margin.

What is Amgen's earnings per share?

Amgen's diluted EPS over the trailing twelve months is $14.38.

Where does Amgen's income statement data come from?

Every line is extracted from Amgen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Amgen AMGN Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$37.22B+1.3%	$36.75B+2.2%	$35.97B+3.0%	$34.92B+2.3%	$34.13B+2.1%
Total cost of revenue	$11.81B-1.9%	$12.04B-1.1%	$12.17B-1.8%	$12.4B-1.8%	$12.63B-1.8%
Gross profit	$25.41B+2.8%	$24.71B+3.8%	$23.8B+5.7%	$22.52B+4.7%	$21.5B+4.5%
Gross margin	68.3%+1.0pp	67.2%+1.1pp	66.2%+1.7pp	64.5%+1.5pp	63%+1.5pp
Research and development	$7.51B+3.2%	$7.27B+6.1%	$6.85B+7.0%	$6.4B+4.9%	$6.11B+2.4%
Selling, general and administrative	$6.97B-1.2%	$7.05B+1.1%	$6.98B+1.4%	$6.88B-1.3%	$6.98B-1.7%
Total costs & expenses	$26.65B-3.7%	$27.67B+1.4%	$27.3B+2.2%	$26.73B+0.2%	$26.68B+2.0%
Operating income	$10.57B+16.4%	$9.08B+4.7%	$8.67B+5.8%	$8.19B+10.0%	$7.45B+2.6%
Operating margin	28.4%+3.7pp	24.7%+0.6pp	24.1%+0.6pp	23.5%+1.6pp	21.8%+0.1pp
Interest expense	$2.69B-2.4%	$2.76B-3.3%	$2.85B-3.1%	$2.94B-3.7%	$3.05B-3.2%
Other income (expense), net	——	——	——	——	——
Income before income taxes	$9.09B+1.2%	$8.98B+8.9%	$8.24B+11.0%	$7.42B+11.6%	$6.65B+44.3%
Income tax expense	$1.29B+1.7%	$1.27B+2.1%	$1.24B+53.9%	$805M+12.3%	$717M+38.2%
Net income	$7.8B+1.2%	$7.71B+10.1%	$7.01B+5.8%	$6.62B+11.6%	$5.93B+45.1%
Net margin	21%0.0pp	21%+1.5pp	19.5%+0.5pp	19%+1.6pp	17.4%+5.1pp
Diluted earnings per share	$14.38+1.0%	$14.24+10.0%	$12.94+5.8%	$12.23+11.6%	$10.96+45.2%
EBITDA	$15.46B+8.5%	$14.25B+1.0%	$14.1B+2.8%	$13.71B+5.3%	$13.03B+1.4%
EBITDA margin	41.5%+2.8pp	38.8%-0.4pp	39.2%-0.1pp	39.3%+1.1pp	38.2%-0.3pp
EBIT	$10.57B+16.4%	$9.08B+4.7%	$8.67B+5.8%	$8.19B+10.0%	$7.45B+2.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Amgen.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amgen's revenue?: Amgen (AMGN) generated $37.2B in revenue over the trailing twelve months, up 9.1% year over year.
Is Amgen profitable?: Amgen reported $7.8B in net income over the trailing twelve months, a 21.0% net margin.
What are Amgen's profit margins?: Gross margin is 68.3% and operating margin is 28.4%, with a 21.0% net margin.
What is Amgen's earnings per share?: Amgen's diluted EPS over the trailing twelve months is $14.38.
Where does Amgen's income statement data come from?: Every line is extracted from Amgen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.